Kevin Kelly

Kevin Kelly is an Associate Professor of Clinical Medicine at the Keck School of Medicine, University of Southern California, specializing in hematological malignancies and phase I therapeutics. His clinical expertise covers lymphoma, multiple myeloma, and bone marrow transplantation.

Research focuses on chemotherapy resistance mechanisms in blood cancers and developing novel agents like phosphodiesterase inhibitors to overcome treatment barriers. He leads translational projects bridging laboratory discoveries to clinical trials.

Honors include the NCI Clinical Investigator Leadership Award and competitive travel grants from major oncology associations. He mentors fellows in advanced drug development methodologies.